Partner solution

Trakcel Integration

Our combined offering aims to increase speed-to-therapy by increasing connectivity between providers and hub patient services.

We exist to unlock the potential of ground-breaking therapies for healthier futures

TrakCel is a leading supplier of cellular orchestration solutions for clinical trials and commercial therapies to the cell and gene therapy industry. Together, we launched an integrated technology platform designed to accelerate patient access to prescribed cell and gene therapies and deliver complete visibility to physicians and patient services teams across the treatment development and patient journey, enabling seamless care coordination and timely patient engagement. The enhanced offering combines two platforms—OCELLOS , TrakCel’s advanced therapy orchestration platform, and Fusion, a customer relationship management and patient support ecosystem powered by AmerisourceBergen.

Whilst the initial integration, including AmerisourceBergen's advanced electronic benefit verification (eBV) system, powered by machine learning, enabled physicians to quickly determine patient coverage, after creating a patient account and entering enrollment information within a single portal; the latest features now offer physicians and case managers even greater visibility into the progression of the treatment, from cell order submission and sample collection to the manufacturing and transportation of the final product.

Available in English only

Press release

With the integration between OCELLOS and Fusion, we are entering a new phase in therapy ecosystem connectivity.

“This integration will ensure that all those involved in the supply and value chains of cell and gene therapies will be able to be kept up to the minute about the progression of a therapy as well as reimbursement and benefit eligibility, allowing them to schedule treatments and appointments more effectively and sympathetically and keep patients better informed.”

Ravi Nalliah
Chief Product and Strategy Officer, TrakCel

Available in English only

Article

Interview: Increasing advanced therapies’ connectivity and speed to market through partnership

“Through this collaboration with TrakCel, we are able to improve speed-to-therapy and simplify the care coordination process to help deliver an enhanced patient and provider experience.”
Dale Hanna
Director, Cell and Gene Therapies, AmerisourceBergen

 

 

Connect with our Cell and Gene experts

Groundbreaking cell and gene therapies are paving the path to a healthier tomorrow. And because these life-changing products require equally innovative commercialization partners, we are committed to solutions that light the way so your product reaches the patients who need it.

Schedule time with our experts to discuss: 

  • Clinical development strategy
  •  Regulatory consulting
  • Global courier services
  • 3PL Logistics 
  • Distribution
  • Market access and reimbursement
  • Pharmacovigilance 
  • Patient support